Dr. Ravindra is an experienced radiation oncologist practising at HCG Cancer Centre.
He has 10+ years of experience in the field of oncology as a specialist physician and teaching faculty.
His primary interest lies in high precision radiotherapy and radiosurgery and brachytherapy. His secondary interest lies in palliative care.
Dr. Ravindra is highly oriented towards preventive oncology and related services, specific practice of high precision radiotherapy and radiosurgery procedures, performing innovative brachytherapy procedures using 3-D print technology and conducting cancer awareness programmes.
He is also interested in organising teaching and academic programmes for oncology postgraduates.
Dr. Ravindra has so far handled 7000 cases.
Dr. Ravindra was the runner-up of a Brachytherapy Quiz that was conducted at CMC, Vellore, Tamil Nadu.
He was the recipient of the Travel Fellowship Award at Aroicon 2011, Jaipur.
He was also the winner of AROI (Karnataka chapter) PG-Quiz 2012, Bengaluru.
He was the topper at the 13th ICRO 2012 held at Bhatinda, Punjab.
Dr. Ravindra was also the winner of the PG Quiz at YROI 2013 held at Thalassery, Kerala.
All that Glitters…disadvantages of IMRT. Dr Bindu, Dr Supe, Dr Ravindra, Dr Pawar - Published in Oncoscope June 2009.
Situs Inversus Totalis Discovered Incidentally at the Age of 84 Years. BMJ Case Rep. 2013 Mar 12;2013:bcr2013008611.
Response Evaluation & Complication Comparison of Concurrent Chemoradiation Among Patients with Carcinoma Cervix Stage 2A – 4A.
Weekly Cisplatin vs Weekly Cisplatin -Prospective Study.
Dose Escalation Study among Patients with Unresectable Carcinoma Oesophagus treated with Radical Intent with Brachytherapy Boost.
Role of Neoadjuvant Chemotherapy (Taxane Based) In Unresectable Head & Neck Cancer Patients. A Prospective Study.
HCG - The Specialist in Cancer Care, India’s largest provider of cancer care, is at the forefront of the battle against cancer. Through its network of 21 comprehensive cancer centers, spread across India, HCG has brought advanced cancer care to the doorstep of millions of people.